Coronavirus Update: Superior Tolerability Was Behind Pfizer/BioNTech’s Vaccine Switch
Far Fewer Suffered Fever Symptoms
• By Scrip Team
Pfizer and BioNTech's vaccine candidate is expected to be one of the first to gain approval, potentially as early as October. 
